Last Price
0.014
Today's Change
+0.001 (7.69%)
Day's Change
0.013 - 0.014
Trading Volume
4,041,458
Market Cap
52 Million
Shares Outstanding
3 Billion
Avg Volume
8,250,965
Avg Price (50 Days)
0.01
Avg Price (200 Days)
0.01
PE Ratio
-1.40
EPS
-0.01
Earnings Announcement
25-Feb-2025
Previous Close
0.01
Open
0.01
Day's Range
0.013 - 0.014
Year Range
0.004 - 0.015
Trading Volume
4,041,458
1 Day Change
7.69%
5 Day Change
0.00%
1 Month Change
16.67%
3 Month Change
133.33%
6 Month Change
180.00%
Ytd Change
64.70%
1 Year Change
48.23%
3 Year Change
-60.71%
5 Year Change
-71.89%
10 Year Change
-82.88%
Max Change
-92.21%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.